Das Arzneimittelmarktneuordnungsgesetz aus kinder- und jugendpsychiatrischer Perspektive = The new German drug market law AMNOG from a child andadolescent psychiatry perspective
Background: The European Union (EU) regulation 1901/2006 plus the implementation of pediatric investigational plans by the European Medicines Agency (EMA) have contributed to more clinical studies in pediatric psychopharmacology. A new drug market law (AMNOG) has been in force in Germany since 2011...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article (Journal) |
| Language: | German English |
| Published: |
18. März 2016
|
| In: |
Der Nervenarzt
Year: 2016, Volume: 87, Issue: 4, Pages: 367-375 |
| ISSN: | 1433-0407 |
| DOI: | 10.1007/s00115-016-0094-0 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1007/s00115-016-0094-0
|
| Author Notes: | R.W. Dittmann |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 166273333X | ||
| 003 | DE-627 | ||
| 005 | 20230426154235.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190402s2016 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00115-016-0094-0 |2 doi | |
| 035 | |a (DE-627)166273333X | ||
| 035 | |a (DE-599)KXP166273333X | ||
| 035 | |a (OCoLC)1341205996 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a ger |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Dittmann, Ralf |e VerfasserIn |0 (DE-588)1032941170 |0 (DE-627)739784323 |0 (DE-576)38041337X |4 aut | |
| 245 | 1 | 4 | |a Das Arzneimittelmarktneuordnungsgesetz aus kinder- und jugendpsychiatrischer Perspektive |b = The new German drug market law AMNOG from a child andadolescent psychiatry perspective |c R.W. Dittmann |
| 246 | 3 | 1 | |a The new German drug market law AMNOG from a child andadolescent psychiatry perspective |
| 264 | 1 | |c 18. März 2016 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 02.04.2019 | ||
| 520 | |a Background: The European Union (EU) regulation 1901/2006 plus the implementation of pediatric investigational plans by the European Medicines Agency (EMA) have contributed to more clinical studies in pediatric psychopharmacology. A new drug market law (AMNOG) has been in force in Germany since 2011 that requires an additional process of assessment of benefits of newly authorized medications by the Federal Joint Committee (Gemeinsamer Bundesausschuss, G‑BA), which also holds for medications licensed for pediatric populations. Objectives: Summary of early assessments of benefits for newly registered compounds in the treatment of psychiatric disorders and critical discussion from the perspective of child and adolescent psychiatry. Material and methods: Application and critical review of documents and written statements by various institutions and stakeholders related to assessment procedures and respective decisions by the G‑BA for these medications. Results and conclusion: Clearly differing requirements for study designs and outcome parameters characterize the conditions for market authorization and for the assessment of benefits. Further adjustments to the regulations in implementing the AMNOG appear to be essential, integrating agencies involved so far, complimented by expertise from regulatory agencies and medical scientific societies. | ||
| 650 | 4 | |a Arzneimittelmarktneuordnungsgesetz | |
| 650 | 4 | |a Assessment of benefit and costs | |
| 650 | 4 | |a Child and adolescent psychiatry | |
| 650 | 4 | |a Clinical studies | |
| 650 | 4 | |a German new drug market law | |
| 650 | 4 | |a Kinder- und Jugendpsychiatrie | |
| 650 | 4 | |a Klinische Studien | |
| 650 | 4 | |a Nutzenbewertung | |
| 650 | 4 | |a Psychopharmacology | |
| 650 | 4 | |a Psychopharmakologie | |
| 773 | 0 | 8 | |i Enthalten in |t Der Nervenarzt |d Berlin : Springer, 1996 |g 87(2016), 4, Seite 367-375 |h Online-Ressource |w (DE-627)25463835X |w (DE-600)1462945-8 |w (DE-576)074531468 |x 1433-0407 |7 nnas |a Das Arzneimittelmarktneuordnungsgesetz aus kinder- und jugendpsychiatrischer Perspektive = The new German drug market law AMNOG from a child andadolescent psychiatry perspective |
| 773 | 1 | 8 | |g volume:87 |g year:2016 |g number:4 |g pages:367-375 |g extent:9 |a Das Arzneimittelmarktneuordnungsgesetz aus kinder- und jugendpsychiatrischer Perspektive = The new German drug market law AMNOG from a child andadolescent psychiatry perspective |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00115-016-0094-0 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190402 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1032941170 |a Dittmann, Ralf |m 1032941170:Dittmann, Ralf |d 60000 |e 60000PD1032941170 |k 0/60000/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN166273333X |e 3417785936 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"roleDisplay":"VerfasserIn","display":"Dittmann, Ralf","role":"aut","family":"Dittmann","given":"Ralf"}],"title":[{"title":"Das Arzneimittelmarktneuordnungsgesetz aus kinder- und jugendpsychiatrischer Perspektive","subtitle":" = The new German drug market law AMNOG from a child andadolescent psychiatry perspective","title_sort":"Arzneimittelmarktneuordnungsgesetz aus kinder- und jugendpsychiatrischer Perspektive"}],"note":["Gesehen am 02.04.2019"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"166273333X","language":["ger","eng"],"titleTranslated":[{"translated":"The new German drug market law AMNOG from a child andadolescent psychiatry perspective"}],"name":{"displayForm":["R.W. Dittmann"]},"origin":[{"dateIssuedDisp":"18. März 2016","dateIssuedKey":"2016"}],"id":{"doi":["10.1007/s00115-016-0094-0"],"eki":["166273333X"]},"physDesc":[{"extent":"9 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1433-0407"],"zdb":["1462945-8"],"eki":["25463835X"]},"origin":[{"dateIssuedKey":"1996","publisher":"Springer ; Springer","dateIssuedDisp":"1996-","publisherPlace":"Berlin ; Heidelberg ; Berlin ; Heidelberg ; New York, NY"}],"recId":"25463835X","language":["ger"],"disp":"Das Arzneimittelmarktneuordnungsgesetz aus kinder- und jugendpsychiatrischer Perspektive = The new German drug market law AMNOG from a child andadolescent psychiatry perspectiveDer Nervenarzt","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 18.10.06","Ungezählte Beil.: Supplement"],"part":{"year":"2016","pages":"367-375","issue":"4","text":"87(2016), 4, Seite 367-375","volume":"87","extent":"9"},"titleAlt":[{"title":"Organ von: Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde ; Mitteilungsblatt von: Deutsche Gesellschaft für Neurologie, Gesellschaft Österreichischer Nervenärzte und Psychiater ; begründet 1928"}],"pubHistory":["Nachgewiesen 67.1996,8 -"],"title":[{"title_sort":"Nervenarzt","subtitle":"Organ der Deutschen Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde ; Mitteilungsblatt der Deutschen Gesellschaft für Neurologie","title":"Der Nervenarzt"}]}]} | ||
| SRT | |a DITTMANNRAARZNEIMITT1820 | ||